SCHEDULE: Intracoastal Capital Discloses 9.99% Stake in GeoVax Labs

Intracoastal Capital LLC and its principals reported a 9.99% passive beneficial ownership stake in GeoVax Labs, Inc. through warrants.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (the "Reporting Persons") collectively reported beneficial ownership of 4,806,174 shares of GeoVax Labs, Inc. common stock.
• This ownership represents approximately 9.99% of the company's common stock.
• The shares beneficially owned consist of 4,081,632 shares issuable upon exercise of Intracoastal Warrant 1 and 724,542 shares issuable upon exercise of Intracoastal Warrant 2.
• The calculation of the 9.99% ownership is based on 43,303,682 shares outstanding as of December 22, 2025, plus the shares issuable from the exercised warrants.
• The warrants include blocker provisions preventing the holder from exercising them to the extent that beneficial ownership would exceed 9.99% (for Warrant 2) or 4.99% (for Warrant 3).
• Without these blocker provisions, the Reporting Persons would have beneficial ownership of 9,095,760 shares of Common Stock.
• The Reporting Persons share both voting and dispositive power over the 4,806,174 beneficially owned shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine disclosure of a significant passive stake, which is generally neutral unless the stake size or nature suggests a strategic shift. The presence of blocker provisions indicates a clear intent to remain below control thresholds.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings indicate passive investment intent, distinguishing them from Schedule 13D filings which suggest potential influence or control. This disclosure highlights a significant institutional stake in GeoVax Labs, signaling investor interest without an immediate intent to alter company strategy or control.

Comparison to Industry Standards

• Schedule 13G filings are a standard regulatory requirement for passive investors who acquire more than 5% of a company's voting securities, indicating a non-controlling interest. This filing aligns with typical disclosure practices for such ownership thresholds.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake could be viewed positively as a vote of confidence, though the passive nature limits immediate strategic impact. Potential future dilution exists if the warrants are fully exercised.

Key Dates

Recommendation

The filing indicates a significant passive stake by Intracoastal Capital LLC and its principals in GeoVax Labs, Inc. While this demonstrates institutional interest, the 'passive' nature of the 13G filing suggests no immediate intent to influence control or strategy. The existence of blocker provisions also limits the immediate impact on the outstanding share count from warrant exercise. Therefore, a 'hold' recommendation is appropriate as this disclosure alone does not provide new fundamental information to warrant a 'buy' or 'sell' decision, but it acknowledges a notable institutional position.

Keywords

GeoVax Labs, Intracoastal Capital, Beneficial Ownership, Schedule 13G, Common Stock, Warrants, Institutional Investor, Passive Investment